WuXi Biologics inks lease agreement for 3rd U.S. facility in global expansion push kblankenship Tue, 06/09/2020 – 09:18
Category: Uncategorized
Sanofi’s Sarclisa rejected by NICE over uncertainties on total benefit, cost-effectiveness esagonowsky Tue, 06/09/2020 – 11:02
Fujifilm plots $890M infusion at Danish biologics plant to double production capacity kblankenship Tue, 06/09/2020 – 13:13
Virus DNA left on a hospital bed rail was found in nearly half of all sites sampled across […]
Rice University neuroengineers have created a tiny surgical implant that can electrically stimulate the brain and nervous system […]
The move follows a portfolio review by the French drug giant
The study failed to meet statistical significance for the primary endpoint, however, it did show a number of […]
The research also suggests that coronavirus was more infectious than previously estimated
It is not certain how much more clinical benefit Sarclisa has over existing therapies, the Institute said
